UnitedHealth Group (UNH) to Release Earnings on Tuesday

Share on StockTwits

UnitedHealth Group (NYSE:UNH) is set to post its quarterly earnings results before the market opens on Tuesday, October 15th. Analysts expect UnitedHealth Group to post earnings of $3.77 per share for the quarter. UnitedHealth Group has set its FY 2019 guidance at $14.70-14.90 EPS and its FY19 guidance at $14.70-14.90 EPS.Individual interested in registering for the company’s earnings conference call can do so using this link.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.46 by $0.14. The firm had revenue of $60.60 billion for the quarter, compared to analyst estimates of $60.59 billion. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The business’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $3.14 EPS. On average, analysts expect UnitedHealth Group to post $15 EPS for the current fiscal year and $17 EPS for the next fiscal year.

UNH stock opened at $222.07 on Friday. The firm has a market cap of $210.46 billion, a PE ratio of 17.24, a PEG ratio of 1.18 and a beta of 0.60. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.67 and a current ratio of 0.67. The firm’s 50 day moving average price is $227.16 and its 200-day moving average price is $240.09. UnitedHealth Group has a one year low of $208.07 and a one year high of $287.94.

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a dividend of $1.08 per share. This represents a $4.32 annualized dividend and a dividend yield of 1.95%. The ex-dividend date of this dividend was Friday, September 13th. UnitedHealth Group’s payout ratio is presently 33.54%.

Several analysts have recently commented on the stock. Cantor Fitzgerald set a $310.00 price target on shares of UnitedHealth Group and gave the company a “buy” rating in a research report on Tuesday, October 8th. Zacks Investment Research raised shares of UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price target on the stock in a research report on Monday, July 22nd. Deutsche Bank assumed coverage on shares of UnitedHealth Group in a research report on Thursday, September 12th. They set a “hold” rating and a $263.00 price target on the stock. BMO Capital Markets lowered shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and reduced their price target for the company from $292.00 to $249.00 in a research report on Monday, September 30th. Finally, Morgan Stanley reduced their price target on shares of UnitedHealth Group from $298.00 to $294.00 and set an “overweight” rating on the stock in a research report on Thursday, September 26th. Five equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $283.22.

In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction on Thursday, September 19th. The shares were sold at an average price of $233.40, for a total value of $583,500.00. Following the completion of the transaction, the director now owns 187,979 shares in the company, valued at $43,874,298.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director William C. Ballard, Jr. sold 12,000 shares of the business’s stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the completion of the transaction, the director now owns 61,309 shares of the company’s stock, valued at approximately $15,652,800.79. The disclosure for this sale can be found here. In the last three months, insiders sold 24,000 shares of company stock worth $5,924,120. 0.87% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: Moving Average (MA)

Earnings History for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.